Skip to main content

Advertisement

Log in

Abstract

Alzheimer’s disease (AD) is increasing in prevalence. There are no known preventive or curative measures. There is evidence that oxidative stress, homocysteinerelated vitamins, fats, and alcohol have a role in the pathogenesis of AD. Some epidemiologic studies suggest that higher dietary intake of antioxidants, vitamins B6, B12, and folate, unsaturated fatty acids, and fish are related to a lower risk of AD, but reports are inconsistent. Modest to moderate alcohol intake, particularly wine, may be related to a lower risk of AD. The Mediterranean diet may also be related to lower AD risk. However, randomized clinical trials of supplements of vitamins E, B12, B6, and folate have shown no cognitive benefit, and randomized trials for other nutrients or diets in AD are not available. The existing evidence does not support the recommendation of specific supplements, foods, or diets for the prevention of AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Luchsinger JA, Mayeux R: Dietary factors and Alzheimer’s disease. Lancet Neurol 2004, 3:579–587.

    Article  PubMed  Google Scholar 

  2. Cummings JL: Alzheimer’s disease. N Engl J Med 2004, 351:56–67.

    Article  PubMed  CAS  Google Scholar 

  3. Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998, 88:1337–1342.

    Article  PubMed  CAS  Google Scholar 

  4. Selkoe DJ: Alzheimer’s disease: genotypes, phenotypes, and treatments. Science 1997, 275:630–631.

    Article  PubMed  CAS  Google Scholar 

  5. Berglund L: The APOE gene and diets: food (and drink) for thought. Am J Clin Nutr 2001, 73:669–670.

    PubMed  CAS  Google Scholar 

  6. Luchsinger J, Mayeux R: Cardiovascular risk factors and Alzheimer’s disease. Curr Atheroscler Rep 2004, 6:261–266.

    Article  PubMed  Google Scholar 

  7. Selkoe DJ: The origins of Alzheimer disease: a is for amyloid. JAMA 2000, 283:1615–1617.

    Article  PubMed  CAS  Google Scholar 

  8. Pitchumoni SS, Doraiswamy PM: Current status of antioxidant therapy for Alzheimer’s Disease. J Am Geriatr Soc 1998, 46:1566–1572.

    PubMed  CAS  Google Scholar 

  9. Neuropathology Group: Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales: Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001, 357:169–175.

    Article  Google Scholar 

  10. Masaki KH, Losonczy KG, Izmirlian G, et al.: Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000, 54:1265–1272.

    PubMed  CAS  Google Scholar 

  11. Zandi PP, Anthony JC, Khachaturian AS, et al.: Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: The Cache County Study. Arch Neurol 2004, 61:82–88.

    Article  PubMed  Google Scholar 

  12. Engelhart MJ, Geerlings MI, Ruitenberg A, et al.: Dietary intake of antioxidants and risk of Alzheimer disease [see comment]. JAMA 2002, 287:3223–3229.

    Article  PubMed  CAS  Google Scholar 

  13. Morris MC, Evans DA, Bienias JL, et al.: Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002, 287:3230–3237.

    Article  PubMed  CAS  Google Scholar 

  14. Luchsinger JA, Tang MX, Shea S, Mayeux R: Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003, 60:203–208.

    Article  PubMed  Google Scholar 

  15. Sano M, Ernesto C, Thomas RG, et al.: A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study. N Engl J Med 1997, 336:1216–1222.

    Article  PubMed  CAS  Google Scholar 

  16. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004, 256:183–194.

    Article  PubMed  CAS  Google Scholar 

  17. Petersen RC, Thomas RG, Grundman M, et al.: Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005, 352:2379–2388.

    Article  PubMed  CAS  Google Scholar 

  18. Miller ER 3rd, Pastor-Barriuso R, Dalal D, et al.: Metaanalysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37–46.

    PubMed  CAS  Google Scholar 

  19. Seshadri S, Beiser A, Selhub J, et al.: Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002, 346:476–483.

    Article  PubMed  CAS  Google Scholar 

  20. Selhub J, Jacques PF, Wilson PW, et al.: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993, 270:2693–2698.

    Article  PubMed  CAS  Google Scholar 

  21. Seshadri S, Wolf PA: Homocysteine and the brain: vascular risk factor or neurotoxin? Lancet Neurol 2003, 2:11.

    Article  PubMed  Google Scholar 

  22. Snowdon DA, Tully CL, Smith CD, et al.: Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr 2000, 71:993–998.

    PubMed  CAS  Google Scholar 

  23. Luchsinger JA, Tang MX, Shea S, et al.: Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004, 62:1972–1976.

    PubMed  CAS  Google Scholar 

  24. Haan MN, Miller JW, Aiello AE, et al.: Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2007, 85:511–517.

    PubMed  CAS  Google Scholar 

  25. Wang HX, Wahlin A, Basun H, et al.: Vitamin B(12) and folate in relation to the development of Alzheimer’s disease. Neurology 2001, 56:1188–1194.

    PubMed  CAS  Google Scholar 

  26. Crystal HA, Ortof E, Frishman WH, et al.: Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1994, 42:933–936.

    PubMed  CAS  Google Scholar 

  27. Morris MC, Evans DA, Schneider JA, et al.: Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer’s disease. J Alzheimers Dis 2006, 9:435–443.

    PubMed  Google Scholar 

  28. Morris MC, Evans DA, Bienias JL, et al.: Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol 2005, 62:641–645.

    Article  PubMed  Google Scholar 

  29. Luchsinger JA, Tang MX, Miller J, et al.: Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007, 64:86–92.

    Article  PubMed  Google Scholar 

  30. Morris MS, Jacques PF, Rosenberg IH, Selhub J: Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007, 85:193–200.

    PubMed  CAS  Google Scholar 

  31. Toole JF, Malinow MR, Chambless LE, et al.: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial. JAMA 2004, 291:565–575.

    Article  PubMed  CAS  Google Scholar 

  32. McMahon JA, Green TJ, Skeaff CM, et al.: A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006, 354:2764–2772.

    Article  PubMed  CAS  Google Scholar 

  33. Kruman II, Culmsee C, Chan SL, et al.: Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000, 20:6920–6926.

    PubMed  CAS  Google Scholar 

  34. Hu FB, Willett WC: Optimal diets for prevention of coronary heart disease. JAMA 2002, 288:2569–2578.

    Article  PubMed  CAS  Google Scholar 

  35. Cohn JS: Oxidized fat in the diet, postprandial lipaemia, and cardiovascular disease. Curr Opin Lipidol 2002, 13:19–24.

    Article  PubMed  CAS  Google Scholar 

  36. Luchsinger JA, Tang MX, Shea S, Mayeux R: Caloric intake and the risk of Alzheimer disease. Arch Neurol 2002, 59:1258–1263.

    Article  PubMed  Google Scholar 

  37. Morris MC, Evans DA, Bienias JL, et al.: Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 2003, 60:194–200.

    Article  PubMed  Google Scholar 

  38. Morris MC, Evans DA, Bienias JL, et al.: Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease [see comment]. Arch Neurol 2003, 60:940–946.

    Article  PubMed  Google Scholar 

  39. Engelhart MJ, Geerlings MI, Ruitenberg A, et al.: Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002, 287:3223–3229.

    Article  PubMed  CAS  Google Scholar 

  40. Pi-Sunyer FX: Glycemic index and disease. Am J Clin Nutr 2002, 76S:290–298.

    Google Scholar 

  41. Luchsinger JA, Tang MX, Shea S, Mayeux R: Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004, 63:1187–1192.

    PubMed  Google Scholar 

  42. Luchsinger JA, Tang MX, Mayeux R: Glycemic load and risk of Alzheimer’s disease. J Nutr Health Aging 2007, In press.

  43. Mukamal KJ, Longstreth WT Jr, Mittleman MA, et al.: Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the cardiovascular health study. Stroke 2001, 32:1939–1946.

    PubMed  CAS  Google Scholar 

  44. Sacco RL, Elkind M, Boden-Albala B, et al.: The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999, 281:53–60.

    Article  PubMed  CAS  Google Scholar 

  45. Heinonen IM, Lehtonen PJ, Hopia AI: Antioxidant activity of berry and fruit wines and liquors. J Agric Food Chem 1998, 46:25–31.

    Article  PubMed  CAS  Google Scholar 

  46. Mukamal KJ, Kuller LH, Fitzpatrick AL, et al.: Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 2003, 289:1405–1413.

    Article  PubMed  CAS  Google Scholar 

  47. Ruitenberg A, van Swieten JC, Witteman JC, et al.: Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 2002, 359:281–286.

    Article  PubMed  Google Scholar 

  48. Truelsen T, Thudium D, Grønbæk M, Copenhagen City Heart Study: Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology 2002, 59:1313–1319.

    PubMed  Google Scholar 

  49. Luchsinger JA, Tang MX, Siddiqui M, et al.: Alcohol intake and risk of dementia. J Am Geriatr Soc 2004, 52:540–546.

    Article  PubMed  Google Scholar 

  50. Orgogozo JM, Dartigues JF, Lafont S, et al.: Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 1997, 153:185–192.

    CAS  Google Scholar 

  51. Linday J, Laurin D, Verreault R: Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002, 156:445–453.

    Article  Google Scholar 

  52. Trichopoulos D, Lagiou P: Mediterranean diet and cardiovascular epidemiology. Eur J Epidemiol 2004, 19:7–8.

    PubMed  CAS  Google Scholar 

  53. Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D: Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev 2000, 9:869–873.

    PubMed  CAS  Google Scholar 

  54. Trichopoulou A, Orfanos P, Norat T, et al.: Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ 2005, 330:991.

    Article  PubMed  Google Scholar 

  55. Scarmeas N, Stern Y, Tang MX, et al.: Mediterranean diet and risk for Alzheimer’s disease. Ann Neurol 2006, 59:912–921.

    Article  PubMed  Google Scholar 

  56. Thiébaut AC, Freedman LS, Carroll RJ, Kipnis V: Is it necessary to correct for measurement error in nutritional epidemiology? Ann Intern Med 2007, 146:65–67.

    PubMed  Google Scholar 

  57. Devanand DP, Michaels-Marston KS, Liu X, et al.: Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. Am J Psychiatry 2000, 157:1399–1405.

    Article  PubMed  CAS  Google Scholar 

  58. Shumaker SA, Legault C, Rapp SR, et al.: Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289:2651–2662.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José A. Luchsinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luchsinger, J.A., Noble, J.M. & Scarmeas, N. Diet and Alzheimer’s disease. Curr Neurol Neurosci Rep 7, 366–372 (2007). https://doi.org/10.1007/s11910-007-0057-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-007-0057-8

Keywords

Navigation